SCHEMBL2214893

SCHEMBL2214893

CC(=O)Nc1cccc(-c2ccc(-c3cc4ccnn4c(Nc4ccc(NC(=O)c5ccc6c(c5)CCN(C(=O)OC(C)(C)C)C6)cc4)n3)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.40
MTOR P42345 1/20 0.40
ABL1 P00519 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39
ROCK2 O75116 1/20 0.39
ESR2 Q92731 1/20 0.38
PDGFRA P16234 1/20 0.37
KDR P35968 1/20 0.37
NAMPT P43490 1/20 0.37
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
GAA P10253 1/20 0.36
ABCB1 P08183 1/20 0.36
SCN3A Q9NY46 2/20 0.36
SCN4A P35499 1/20 0.36
SCN9A Q15858 1/20 0.36
RAD52 P43351 1/20 0.36
RAF1 P04049 1/20 0.36
BRAF P15056 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2216324 0.91 PLAU (0.43) PIK3CAMTORROCK2ESR2MAPT
SCHEMBL2882070 0.90 PLG (0.43) PIK3CAMTORABL1PDGFRBKIT
SCHEMBL2209752 0.89 ABCB1 (0.41) PIK3CAMTORROCK2ESR2NAMPT
SCHEMBL2214996 0.89 ESR2 (0.41) PIK3CAMTORABL1PDGFRBKIT
SCHEMBL2214210 0.83 WNT1 (0.42) ROCK2RAD52JAK2MAP3K5POLB
SCHEMBL2216413 0.82 CYP17A1 (0.49) MAPTABCB1RAD52BRAFJAK2
SCHEMBL2213296 0.81 JAK2 (0.39) PIK3CAMTORABL1PDGFRBKIT
SCHEMBL2213189 0.80 PTGIR (0.41) NAMPTSCN9AJAK2CYP17A1POLB
SCHEMBL2215002 0.78 JAK2 (0.45) KITPDGFRAMAPTRAD52JAK2
SCHEMBL2211305 0.77 NAMPT (0.47) NAMPTMAPTSCN3ASCN4ASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1797096-B1 PYRAZOLOPYRIMIDINES AS INHIBITORS OF PROTEIN KINASE B (AKT) BAYER SCHERING PHARMA AG (DE) 2011-07-27 EP disclosed